Comentários sobre terror noturno: relato de caso

Universidade Federal de São Paulo (UNIFESP) Department of PsychiatryUniversidade Federal de SãoPaulo Department of PsychobiologyUNIFESP, Department of PsychiatrySciEL

Restless legs syndrome in subjects with a knee prosthesis: evidence that symptoms are generated in the periphery

OBJECTIVE: There are no data adressing the prevalence of restless legs syndrome in subjects who have knee prosthesis. Therefore, we conducted a cross-sectional survey of subjects who underwent knee prosthesis surgery. METHOD: A total of 107 subjects (30 male, 77 female) were interviewed over the telephone regarding restless legs syndrome symptoms. If the patients exhibited symptoms of the syndrome, we conducted face-to-face interviews. Lastly, a therapeutic test with pramipexole was proposed for each subject. RESULTS: In our cohort, 7 males (23%) and 30 females (39%) had restless legs syndrome. Of these, 6 males and 23 females were submitted to face-to-face-interview. Of the males, 5 (83%) had restless legs after the knee surgeryexclusively in the operated leg- and reported no family restless legs history. One man had a prior case of bilateral restless legs syndrome, a positive family history and claimed exacerbation of symptoms in the operated leg. Among the females, 16 (69%) had restless legs prior to surgery. A total of 10 female patients reported bilateral symptoms, with fewer symptoms in the operated leg, while 6 displayed a worse outcome in the operated leg. The 7 females (31%) without restless legs prior to surgery and without a family history experienced symptoms only in the operated leg. All subjects responded favorably to the pramipexole therapeutic test. CONCLUSION: Our results suggest that secondary unilateral restless legs syndrome may ensue from knee prosthesis surgery and that the symptoms are generated in the peripheral nervous system

Saint John's wort, an herbal inducer of the cytochrome P4503A4 isoform, may alleviate symptoms of Willis-Ekbom's disease

OBJECTIVE: Certain drug classes alleviate the symptoms of Willis-Ekbom's disease, whereas others aggravate them. The pharmacological profiles of these drugs suggest that drugs that alleviate Willis-Ekbom's disease inhibit thyroid hormone activity, whereas drugs that aggravate Willis-Ekbom's disease increase thyroid hormone activity. These different effects may be secondary to the opposing actions that drugs have on the CYP4503A4 enzyme isoform. Drugs that worsen the symptoms of the Willis-Ekbom's disease inhibit the CYP4503A4 isoform, and drugs that ameliorate the symptoms induce CYP4503A4. The aim of this study is to determine whether Saint John's wort, as an inducer of the CYP4503A4 isoform, diminishes the severity of Willis-Ekbom's disease symptoms by increasing the metabolism of thyroid hormone in treated patients. METHODS: In an open-label pilot trial, we treated 21 Willis-Ekbom's disease patients with a concentrated extract of Saint John's wort at a daily dose of 300 mg over the course of three months. RESULTS: Saint John's wort reduced the severity of Willis-Ekbom's disease symptoms in 17 of the 21 patients. CONCLUSION: Results of this trial suggest that Saint John's wort may benefit some Willis-Ekbom's disease patients. However, as this trial was not placebo-controlled, the extent to which Saint John's wort is effective as a Willis-Ekbom's disease treatment will depend on future, blinded placebo-controlled studies.Faculdade de Medicina de Jundiaí PediatriaUniversidade Federal de São Paulo (UNIFESP) Departamento de PsicobiologiaUniversidade de São Paulo Faculdade de Medicina Hospital das ClínicasUNIFESP, Depto. de PsicobiologiaSciEL

Air stacking and chest compression increase peak cough flow in patients with Duchenne muscular dystrophy

OBJECTIVE: To evaluate cough efficiency using two manually-assisted cough techniques. METHODS: We selected 28 patients with Duchenne muscular dystrophy. The patients were receiving noninvasive nocturnal ventilatory support and presented FVC values < 60% of predicted. Peak cough flow (PCF) was measured, with the patient seated, at four time points: at baseline, during a spontaneous maximal expiratory effort (MEE); during an MEE while receiving chest compression; during an MEE after air stacking with a manual resuscitation bag; and during an MEE with air stacking and compression (combined technique). The last three measurements were conducted in random order. The results were compared using Pearson's correlation test and ANOVA with repeated measures, followed by Tukey's post-hoc test (p < 0.05). RESULTS: The mean age of the patients was 20 ± 4 years, and the mean FVC was 29 ± 12%. Mean PCF at baseline, with chest compression, after air stacking and with the use of the combined technique was 171 ± 67, 231 ± 81, 225 ± 80, and 292 ± 86 L/min, respectively. The results obtained with the use of the combined technique were significantly better than were those obtained with the use of either technique alone (F[3.69] = 67.07; p < 0.001). CONCLUSIONS: Both chest compression and air stacking techniques were efficient in increasing PCF. However, the combination of these two techniques had a significant additional effect (p < 0.0001).OBJETIVO: Avaliar a eficiência da tosse através do uso de duas manobras manuais de auxílio à tosse. MÉTODOS: Foram selecionados 28 pacientes portadores de distrofia muscular de Duchenne em uso de ventilação mecânica não-invasiva noturna e CVF < 60% do previsto. O pico de fluxo da tosse (PFT) foi medido, com o paciente sentado, em quatro momentos: com esforço expiratório máximo (EEM) de forma espontânea (basal), EEM associado à compressão torácica, EEM após empilhamento de ar com bolsa de ventilação e EEM com o uso dessas duas técnicas (técnica combinada). As três últimas medições foram realizadas em ordem aleatória. Os resultados foram comparados usando o teste de correlação de Pearson e ANOVA para medidas repetidas, seguido do teste post hoc de Tukey (p < 0,05). RESULTADOS: A idade média dos pacientes foi de 20 ± 4 anos, e a CVF média foi de 29 ± 12%. A média de PFT basal, com compressão torácica, com empilhamento de ar e com o uso da técnica combinada foi 171 ± 67, 231 ± 81, 225 ± 80, e 292 ±86 L/min, respectivamente. Os resultados com o uso da técnica combinada foram maiores que aqueles com o uso das duas técnicas separadamente [F(3,69) = 67,07; p < 0,001]. CONCLUSÕES: As técnicas de compressão torácica e de empilhamento de ar foram eficientes para aumentar o PFT. No entanto, a combinação dessas manobras teve um efeito aditivo significativo (p < 0,0001).Universidade Federal de São Paulo (UNIFESP) Departamento de PsicobiologiaUNIFESP, Depto. de PsicobiologiaSciEL

Sleep in psychiatric disorders

Altered sleep patterns are prominent in the majority of psychiatric disorders. This article examines the psychiatric disorders that are most often associated to sleep dysfunction as it is related in clinical practice and describes the polysomnographic findings. Patient's main complaints are related to difficulty in initiating and maintaining sleep (initial or middle insomnia, respectively) and poor quality of sleep. Early awakening or terminal insomnia is most described in the depressive conditions. Hypersomnia may be the main symptom in some depressive disorders, as seasonal depression, depression with atypical features or depressive episodes in bipolar disorder. Polysomnographic evaluation shows, in general, a significative reduction in the efficiency and total time of sleep, in detriment to the amount of slow wave sleep. The reduction of rapid eye movement (REM) sleep latency is mainly described for the depression, but has also been reported in other psychiatric disorders.O achado de padrões alterados de sono é notável na maioria dos transtornos psiquiátricos. Neste artigo são abordados os transtornos psiquiátricos que mais freqüentemente apresentam alterações de sono na prática clínica e a descrição dos achados polissonográficos. As queixas mais freqüentes dos pacientes são relacionadas à dificuldade para iniciar e manter o sono (insônia inicial e de manutenção, respectivamente) e sono não reparador, observadas na maioria dos transtornos. A insônia terminal ou despertar precoce é mais relacionada a quadros depressivos. A hipersonia pode aparecer em alguns quadros de depressão como sazonal, atípica ou em transtornos bipolares. Em relação aos achados polissonográficos, temos, em geral, redução significativa da eficiência e do tempo total do sono à custa da redução do sono de ondas lentas. A redução da latência para o sono de movimentos oculares rápidos (REM) é descrita principalmente para os quadros depressivos, mas pode aparecer em outras patologias.Universidade Federal de São Paulo (UNIFESP)Universidade de Medicina de Taubaté Faculdade de MedicinaUNIFESPSciEL

Relato de dois casos de pacientes com narcolepsia com melhora dos sintomas após uso de prednisona

This article focuses on 2 clinical case reports of narcoleptic patients who experienced an absence of excessive sleepiness during treatment of other illnesses with 40 mg daily intake of prednisone.Este artigo refere-se à discussão de 2 casos de pacientes portadores de narcolepsia que apresentaram remissão de hipersonolência diurna excessiva durante tratamento de outras doenças com 40 mg de prednisona.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de MedicinaUniversidade Federal de São Paulo (UNIFESP)Universidade Federal de São Paulo (UNIFESP) EPMUniversidade Federal de São Paulo (UNIFESP) EPM Departamento de PsicobiologiaUNIFESP, EPMUNIFESP, EPM, Depto. de PsicobiologiaSciEL

Padrão alternante cíclico em crianças normais de 12 a 24 meses

OBJECTIVE: The aim of this study is to complement existing data on the expression and characteristics of cyclic alternating pattern (CAP) in children, specifically in the 12 to 24 month age bracket. METHOD: Descriptive study. Settings: a university pediatric sleep laboratory. Participants: Twelve normal and healthy subjects (6 girls and 6 boys, mean age 18.9±4.72 months; range 12-24 months underwent a standard polysomnography night recording in our pediatric sleep laboratory. Sleep stages and CAP were analyzed according to standard international rules. RESULTS: CAP rate found in children of 12 to 24 months of age was (25.78±10.18%) and it is characterized by a linear increase of 2% per month, from 12% at 12 months reaching 35% at 24 months. With coefficient of determination R² of 0.91. The duration of A phases was 6.93±1.06 seconds, and B phases was found to last 21.44±2.31 seconds. The number of CAP cycles was 173.25±73.85 with an average index per hour of 33.55±14.61. The number of CAP sequences reached 25.25±9.55 per recording. CAP rate for the different type of A phases are (21.83±9.68%), for A1, (2.43±2.30%) for A3 and (1.67±1.11%) for A2. CONCLUSION: Our study provides normative data on CAP in a group of young children (12 to 24 months). The most salient result of this study is the strong correlation of CAP rate of 2% per month in this age group.OBJETIVO: O objetivo deste estudo é complementar os dados normativos sobre a expressão e as características do padrão alternante cíclico (CAP) em crianças, especificamente na faixa etária de 12 para 24 meses. MÉTODO: Estudo descritivo. Participantes: Doze indivíduos normais e saudáveis (6 meninas e 6 meninos, entre 12-24 meses de idade (média de 18,9±4,72 meses), foram submetidos a uma noite de gravação de polissonografia em nosso laboratório de sono pediátrico. As fases do sono e CAP foram analisados de acordo com padrão e normas internacionais. RESULTADOS: A taxa máxima encontrada em crianças de 12 a 24 meses de idade foi de (25,78%±10,18) e é caracterizada por um aumento linear de 2% ao mês, a partir de 12% em 12 meses atingindo 35% em 24 meses de idade. A duração da fase A foi de 6,93±1,06 segundos, e nas fases B foi encontrado a média de 21,44±2,31 segundos. O número de ciclos CAP foi 173,25±73,85, com um índice médio por hora de 33,55±14,61. O número de sequências CAP chegou a 25,25±9,55 por registro.Os índices dos subtipos de fases A foram (21,83%±9,68), para a A1, (2,43%±2,30) para a A3 e (1,67%±1,11) para A2. CONCLUSÃO: Nosso estudo fornece dados normativos sobre CAP em um grupo de crianças (12 a 24 meses de idade). O resultado mais saliente deste estudo é a forte correlação entre taxa do CAP e idade, mostrando que a cada mês ocorreu o aumento de 2%.Federal University of São Paulo Department of PsychobiologyISR-IST Evolutionary Systems and Biomedical Engineering LabUNIFESP, Department of PsychobiologySciEL

Class II correction improves nocturnal breathing in adolescents

Objective: To examine modifications in sleep pattern and in craniofacial morphology of adolescents with mandibular retrognathism.Materials and Methods: Sixteen subjects at maximum pubertal growth (12.6 years [+/- 11.5 months]) were selected and treated for 12 months with maxillary expansion and mandibular advancement with a Herbst appliance. Cephalometric radiography and magnetic resonance imaging were obtained prior to and after treatment and were compared using the paired Student's t-test or the nonparametric Wilcoxon rank-sum test. Four polysomnographic recordings were obtained with pressurized nasal cannulae and were analyzed by analysis of variance.Results: the length of the mandible was increased, while the antero-posterior position of the maxilla remained stable. the posterior airway space was increased, the length of the tongue was preserved, and the hyoid bone was moved to a more anterior position. After Herbst treatment, sleep efficiency, sleep latency, rapid eye movement (REM) sleep latency, and percentage of REM sleep remained stable. We did observe a reduction (P < .05) in the relative proportions of stage 1 and stage 3-4 (from 4.30 +/- 1.99 to 2.61 +/- 1.83 for stage 1 and from 25.78 +/-. 7.00 to 19.17 +/- 7.58 for stages 3-4) as well as an increase (P < .01) in the percentage of stage 2 after treatment (49.03 +/- 6.25 to 56.90 +/- 6.22). There was a reduction (P < .05) in the number of respiratory effort related arousals (7.06 +/- 5.37 to 1.31 +/- 1.45 per hour of sleep) due to an increase (P < .01) in airway volume.Conclusions: in the short term, the increase in airway space improved nocturnal breathing associated with the correction of mandibular retrognathism. (Angle Orthod. 2011;81:222-228.)Associacao Fundo de Incentivo a Psicofarmacologia (AFIP)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Universidade Federal de São Paulo, Dept Psychobiol, BR-04024002 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Orthodont, BR-04024002 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Psychobiol, BR-04024002 São Paulo, BrazilUniversidade Federal de São Paulo, Dept Orthodont, BR-04024002 São Paulo, BrazilFAPESP: CEPID 98/14303-3Web of Scienc

Narcolepsy

BACKGROUND: Narcolepsy is a chronic neurological syndrome with prevalence between 0.018% and 0.040% without important ethnic differences. Narcolepsy is characterized by excessive daytime sleepiness and cataplexy. The pathophysiology of the illness is not known; even so it possesses genetic marker (allele HLA DQB1 *0602) and with abnormalities in the neurotransmission of hypocretin has been described in patients with narcolepsy. OBJECTIVES: Resume news discoveries in narcolepsy and show diagnoses and treatment options. METHODS: Bibliographic review. RESULTS AND DISCUSSION: The diagnoses of narcolepsy must be done with The International Classification of Sleep Disorders criteria. The hypocretin dosage is the best exam to confirm diagnose in narcoleptic patients with typical cataplexy. The treatment is carried through with behavior actions and symptomatic drugs that promote the vigil and control the cataplexy. Differential diagnoses as schizophrenia, epilepsy, depression and others sleep disorders need to be eliminated.CONTEXTO: Narcolepsia é uma síndrome neurológica crônica com prevalência entre 0,018% e 0,040% da população, sem diferenciações étnicas importantes. Caracteriza-se por sonolência e cataplexia. A fisiopatologia da doença não é totalmente conhecida, embora possua marcador genético (alelo HLA DQB1 *0602) e anormalidades na neurotransmissão de hipocretina descritos recentemente. OBJETIVOS: Resumir as recentes descobertas na narcolepsia e expor possibilidades diagnósticas e terapêuticas. METODOLOGIA: Revisão bibliográfica. RESULTADOS E DISCUSSÃO: O diagnóstico deve seguir os critérios da Classificação Internacional de Sono. A dosagem de hipocretina é o melhor exame para confirmar narcolepsia em pacientes com cataplexia típica. O tratamento deve ser realizado com medidas comportamentais e drogas sintomáticas que promovem a vigília e controlam a cataplexia. Diagnósticos diferenciais como esquizofrenia, epilepsia, depressão e doenças do sono devem ser descartados.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de MedicinaHospital Israelita Albert Einstein Setor de UrgênciasUniversidade de São Paulo Hospital da Clínicas Serviço de HemodiáliseInstituto do SonoUNIFESP-EPM Departamento de PsicobiologiaUNIFESP, EPM, Depto. de PsicobiologiaSciEL

Narcolepsia

BACKGROUND: Narcolepsy is a chronic neurological syndrome with prevalence between 0.018% and 0.040% without important ethnic differences. Narcolepsy is characterized by excessive daytime sleepiness and cataplexy. The pathophysiology of the illness is not known; even so it possesses genetic marker (allele HLA DQB1 *0602) and with abnormalities in the neurotransmission of hypocretin has been described in patients with narcolepsy. OBJECTIVES: Resume news discoveries in narcolepsy and show diagnoses and treatment options. METHODS: Bibliographic review. RESULTS AND DISCUSSION: The diagnoses of narcolepsy must be done with The International Classification of Sleep Disorders criteria. The hypocretin dosage is the best exam to confirm diagnose in narcoleptic patients with typical cataplexy. The treatment is carried through with behavior actions and symptomatic drugs that promote the vigil and control the cataplexy. Differential diagnoses as schizophrenia, epilepsy, depression and others sleep disorders need to be eliminated.CONTEXTO: Narcolepsia é uma síndrome neurológica crônica com prevalência entre 0,018% e 0,040% da população, sem diferenciações étnicas importantes. Caracteriza-se por sonolência e cataplexia. A fisiopatologia da doença não é totalmente conhecida, embora possua marcador genético (alelo HLA DQB1 *0602) e anormalidades na neurotransmissão de hipocretina descritos recentemente. OBJETIVOS: Resumir as recentes descobertas na narcolepsia e expor possibilidades diagnósticas e terapêuticas. METODOLOGIA: Revisão bibliográfica. RESULTADOS E DISCUSSÃO: O diagnóstico deve seguir os critérios da Classificação Internacional de Sono. A dosagem de hipocretina é o melhor exame para confirmar narcolepsia em pacientes com cataplexia típica. O tratamento deve ser realizado com medidas comportamentais e drogas sintomáticas que promovem a vigília e controlam a cataplexia. Diagnósticos diferenciais como esquizofrenia, epilepsia, depressão e doenças do sono devem ser descartados